← Back to the full Peptide Guide overview
Important Disclaimer — Read Before Using This Page
This information is not intended for use by unlicensed individuals or by licensed professionals who lack adequate training and experience in assessing patients for peptide or hormone therapy. All clinical decisions and dosing must be made in consultation with a licensed, experienced physician and a licensed, experienced compounding pharmacist, and should be supported by published clinical studies.
The information presented here has been compiled using Artificial Intelligence, statements from videos and websites by apparent qualified professionals, and available published research. We strongly encourage exhaustive independent research before considering any therapy. Anyone starting a medication they have never taken before should take an extremely conservative approach.
Nothing on this page or in these videos should be taken as medical advice. These materials are provided only to help begin your research. All dosing and treatment decisions should be made between you and your medical providers after proper evaluation. We are not affiliated with any of the doctors whose videos appear on this page.
AOD-9604 Compounded
Category: Fat Metabolism
How it works. AOD-9604 is a synthetic fragment derived from the C-terminal region of human growth hormone, specifically amino acids 176–191. It was designed to preserve the lipolytic (fat-metabolizing) effects of growth hormone without the full growth-promoting, water-retaining, or diabetogenic effects that make GH therapy problematic for many patients. Importantly, AOD-9604 does not meaningfully activate the GH axis or raise IGF-1 the way GH secretagogues do. That is both its theoretical advantage and its practical limitation.
Why a physician might discuss it—and what to expect. AOD-9604 is most defensibly positioned as a modest adjunct: for selected patients who cannot tolerate GLP-1 receptor agonists, who want a low-burden fat-metabolism support agent, or who are combining it with a serious lifestyle modification program. It is not a substitute for semaglutide or tirzepatide if a patient needs significant weight loss. Patients usually do not feel much: no strong appetite suppression, no GLP-1 nausea, no stimulant energy. If it helps, the changes are gradual—modest waist circumference improvement, small body-composition shifts, or lipid marker changes over weeks to months. Expectation management is everything.
Regulatory status. AOD-9604 is not FDA-approved. Its development as an obesity drug did not demonstrate sufficient efficacy to justify approval, despite a relatively clean short-term safety profile from a human trial program of approximately 900 participants. It received GRAS (Generally Recognized as Safe) self-affirmation for some food and cosmetic uses in Australia in 2014, but that is not drug approval. It is prohibited for WADA-tested athletes.
Recommended Videos
Dr. William Seeds — The Genius Life — The Ultimate Peptide Stack To Burn Fat & Build Muscle
Dr. Jones, DC — Doctor Reveals The Fat Burning Peptide That No One is Talking About (AOD-9604)
Dr. Adam Sewell, MD — AOD-9604: The Ultimate Guide to Fat Loss, Tissue Repair, and Metabolic Health
Video Sources & Independence
The videos linked on this page are provided solely for educational purposes. None of the physicians or channels featured are sponsored by, affiliated with, or compensated by NJ Weight Loss & Preventive Care Clinics, its physicians, or any individuals associated with our practice. We have selected these videos because they offer thoughtful, evidence-based discussion of mechanisms and clinical considerations. Viewers should evaluate all sources independently.
← Back to the full Peptide Guide overview · Peptide Dosing Reference →